XML 35 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Operating Activities    
Net income $ 30,337 $ 35,157
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 85,146 80,663
Equity in net (income) loss from unconsolidated joint ventures (5,073) 1,560
Distributions of cumulative earnings from unconsolidated joint ventures 6,901 4,408
Equity in net gain on sale of interest in unconsolidated joint venture interest/real estate   (7,260)
Gain on sale of discontinued operations (1,113) (6,627)
Loan loss and other investment reserves, net of recoveries   564
Loss on early extinguishment of debt 18,513  
Deferred rents receivable (13,923) (21,123)
Other non-cash adjustments (22,115) 5,554
Changes in operating assets and liabilities:    
Restricted cash - operations 5,447 (12,771)
Tenant and other receivables 7,409 14
Related party receivables (3,638) (3,664)
Deferred lease costs (4,646) (7,152)
Other assets (21,185) (24,230)
Accounts payable, accrued expenses and other liabilities 869 4,118
Deferred revenue and land leases payable 19,596 7,620
Net cash provided by operating activities 102,525 56,831
Investing Activities    
Acquisitions of real estate property (48,500) (145,558)
Additions to land, buildings and improvements (11,617) (32,561)
Escrowed cash - capital improvements/acquisition deposits 191 (1,533)
Investments in unconsolidated joint ventures (49,996) (105,633)
Distributions in excess of cumulative earnings from unconsolidated joint ventures 5,333 16,652
Net proceeds from disposition of real estate/joint venture interest 5,852 23,088
Other investments (10,146) (40,016)
Debt and preferred equity and other investments, net of repayments/participations (65,607) (8,631)
Net cash used in investing activities (174,490) (294,192)
Financing Activities    
Proceeds from mortgages and other loans payable 980,333 108,500
Repayments of mortgages and other loans payable (787,887) (13,526)
Proceeds from credit facility and senior unsecured notes 155,000 300,000
Repayments of credit facility and senior unsecured notes (199,960) (352,454)
Proceeds from stock options exercised and DRIP issuance 4,546 102,089
Net proceeds from sale of common stock/preferred stock (57) 122,953
Purchases of treasury stock   (11,158)
Distributions to noncontrolling interests in other partnerships (4,879) (7,117)
Contributions from noncontrolling interests in other partnerships 3,110 18,331
Distributions to noncontrolling interests in the Operating Partnership (853) (762)
Dividends paid on common and preferred stock (38,591) (28,453)
Deferred loan costs and capitalized lease obligations (8,677) (5,569)
Net cash provided by financing activities 102,085 232,834
Net increase (decrease) in cash and cash equivalents 30,120 (4,527)
Cash and cash equivalents at beginning of period 189,984 138,192
Cash and cash equivalents at end of period $ 220,104 $ 133,665